xamoterol has been researched along with opc 21268 in 1 studies
| Studies (xamoterol) | Trials (xamoterol) | Recent Studies (post-2010) (xamoterol) | Studies (opc 21268) | Trials (opc 21268) | Recent Studies (post-2010) (opc 21268) |
|---|---|---|---|---|---|
| 269 | 80 | 17 | 133 | 3 | 6 |
| Protein | Taxonomy | xamoterol (IC50) | opc 21268 (IC50) |
|---|---|---|---|
| Vasopressin V1a receptor | Rattus norvegicus (Norway rat) | 0.44 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashida, W; Kawai, C; Kumada, T | 1 |
1 review(s) available for xamoterol and opc 21268
| Article | Year |
|---|---|
[New oral drugs for the treatment of congestive heart failure].
Topics: Administration, Oral; Cardiotonic Agents; Deoxyepinephrine; Ethanolamines; Heart Failure; Humans; Phosphodiesterase Inhibitors; Piperidines; Propanolamines; Pyrazines; Quinolines; Quinolones; Vasodilator Agents; Xamoterol | 1992 |